Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 140.08% | -226.75% | 25.80% | 8.72% | 62.77% |
| Total Depreciation and Amortization | -- | 301.02% | -201.16% | -- | -- |
| Total Amortization of Deferred Charges | -- | 299.51% | -201.16% | -- | -- |
| Total Other Non-Cash Items | -95.81% | 283.95% | -254.90% | 395.30% | -111.05% |
| Change in Net Operating Assets | -- | -129.98% | 201.16% | -- | -- |
| Cash from Operations | -62.23% | 28.47% | 1,125.93% | -77.23% | -69.65% |
| Capital Expenditure | 39.40% | -3.06% | 15.48% | 19.37% | -11.28% |
| Sale of Property, Plant, and Equipment | -98.39% | 3,496.39% | 153.21% | -146.29% | -52.87% |
| Cash Acquisitions | 99.35% | -1,277.96% | -772.34% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -142.86% | 239.40% | 77.07% | -51,906.59% | -105.11% |
| Cash from Investing | -166.12% | 188.92% | 75.26% | -3,628.31% | -306.59% |
| Total Debt Issued | 3.62% | -59.65% | 16.27% | 206.24% | -5.18% |
| Total Debt Repaid | 84.03% | -62.46% | -69.97% | -772.46% | 89.90% |
| Issuance of Common Stock | -12.10% | -75.03% | 759.22% | 55.87% | -85.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 19.64% | 93.92% | -1,525.70% | -11.03% | -60.30% |
| Other Financing Activities | -242.52% | 182.99% | -602.12% | 122.70% | -78.41% |
| Cash from Financing | 92.82% | -197.68% | -337.38% | 8,233.17% | 100.51% |
| Foreign Exchange rate Adjustments | -66.84% | 163.49% | -458.10% | 227.93% | 61.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -738.15% | 107.17% | 71.47% | -19,432.80% | -45.08% |